Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital

Autor: Angela A. Cleveland, Beatriz L. Gómez, Ángela M. Tobón, Mary E. Brandt, Angela Restrepo, Dedsy Y. Berbesi, Diego H. Cáceres, Christina M. Scheel, Jesús Ochoa, Tom Chiller
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Constitutional symptoms
Hepatosplenomegaly
Lymphadenopathy
HIV Infections
Gastroenterology
0302 clinical medicine
Weight loss
Medicine
Sida
Histoplasmosis
biology
SIDA
Coinfection
Liver enzyme
Headache
Alanine Transaminase
Nausea
Progressive disseminated histoplasmosis
Articles
Infectious Diseases
Acquired immune deficiency syndrome
Female
medicine.symptom
Hepatomegaly
Adult
Diarrhea
medicine.medical_specialty
Tuberculosis
Vomiting
030106 microbiology
030231 tropical medicine
Colombia
Aspartate aminotransferase
03 medical and health sciences
Virology
Internal medicine
Skin Ulcer
Weight Loss
Humans
Aspartate Aminotransferases
Karnofsky Performance Status
Acquired Immunodeficiency Syndrome
business.industry
VIH
Leukopenia
medicine.disease
biology.organism_classification
Enfermedades
Thrombocytopenia
Abdominal Pain
Dyspnea
Cough
Splenomegaly
Immunology
Alanine aminotransferase
Parasitology
business
Zdroj: Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
ISSN: 1476-1645
0002-9637
DOI: 10.4269/ajtmh.15-0837
Popis: Histoplasmosis is common among persons living with human immunodeficiency virus/acquired immune deficiency syndrome (PLWHA) in Latin America, but its diagnosis is difficult and often nonspecific. We conducted prospective screening for histoplasmosis among PLWHA with signs or symptoms suggesting progressive disseminated histoplasmosis (PDH) and hospitalized in Hospital La María in Medellín, Colombia. The study's aim was to obtain a clinical and laboratory profile of PLWHA with PDH. During 3 years (May 2008 to August 2011), we identified 89 PLWHA hospitalized with symptoms suggestive of PDH, of whom 45 (51%) had histoplasmosis. We observed tuberculosis (TB) coinfection in a large proportion of patients with PDH (35%), so all analyses were performed adjusting for this coinfection and, alternatively, excluding histoplasmosis patients with TB. Results showed that the patients with PDH were more likely to have Karnofsky score ≤ 30 (prevalence ratio [PR] = 1.98, 95% confidence interval [CI] = 0.97-4.06), liver compromised with hepatomegaly and/or splenomegaly (PR = 1.77, CI = 1.03-3.06) and elevation in serum of alanine aminotransferase and aspartate aminotransferase to values > 40 mU/mL (PR = 2.06, CI = 1.09-3.88 and PR = 1.53, CI = 0.99-2.35, respectively). Using multiple correspondence analyses, we identified in patients with PDH a profile characterized by the presence of constitutional symptoms, namely weight loss and Karnofsky classification ≤ 30, gastrointestinal manifestations with alteration of liver enzymes and hepatosplenomegaly and/or splenomegaly, skin lesions, and hematological alterations. Study of the profiles is no substitute for laboratory diagnostics, but identifying clinical and laboratory indicators of PLWHAwith PDH should allow development of strategies for reducing the time to diagnosis and thus mortality caused by Histoplasma capsulatum. Copyright © 2016 by The American Society of Tropical Medicine and Hygiene.
Databáze: OpenAIRE